01 4Allergan Inc.
02 2Gilbert's LLP
01 22110454
02 22496780
03 22507002
01 6Silodosin
01 6capsule
01 22013-12-01
02 22023-09-05
03 22023-12-11
Patent Expiration Date : 2023-09-05
Date Granted : 2011-03-15
Brand Name : RAPAFLO
Patent Number : 2496780
Filing Date : 2003-09-05
Strength per Unit : 4 mg
Dosage Form : capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-09-05
Date Granted : 2011-03-15
Patent Expiration Date : 2023-12-11
Date Granted : 2012-09-18
Brand Name : RAPAFLO
Patent Number : 2507002
Filing Date : 2003-12-11
Strength per Unit : 4 mg
Dosage Form : capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-12-11
Date Granted : 2012-09-18
Patent Expiration Date : 2023-09-05
Date Granted : 2011-03-15
Brand Name : RAPAFLO
Patent Number : 2496780
Filing Date : 2003-09-05
Strength per Unit : 8 mg
Dosage Form : capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-09-05
Date Granted : 2011-03-15
Patent Expiration Date : 2023-12-11
Date Granted : 2012-09-18
Brand Name : RAPAFLO
Patent Number : 2507002
Filing Date : 2003-12-11
Strength per Unit : 8 mg
Dosage Form : capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2023-12-11
Date Granted : 2012-09-18
Patent Expiration Date : 2013-12-01
Date Granted : 2005-10-25
Brand Name : RAPAFLO
Patent Number : 2110454
Filing Date : 1993-12-01
Strength per Unit : 4 mg
Dosage Form : capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-12-01
Date Granted : 2005-10-25
Patent Expiration Date : 2013-12-01
Date Granted : 2005-10-25
Brand Name : RAPAFLO
Patent Number : 2110454
Filing Date : 1993-12-01
Strength per Unit : 8 mg
Dosage Form : capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-12-01
Date Granted : 2005-10-25
